Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).
|Number of pages||3|
|Journal||Iranian Journal of Public Health|
|Publication status||Published - 2016|